Viral Prefusion Targeting Using Entry Inhibitor Peptides: The Case of SARS-CoV-2 and Influenza A virus.
Yasaman BehzadipourHajar OwjiPublished in: International journal of peptide research and therapeutics (2022)
The online version contains supplementary material available at 10.1007/s10989-021-10357-y.